UBLCP1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.395990E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.969900E-02
Normal-vs-Stage2
1.682330E-02
Normal-vs-Stage3
7.314300E-02
Normal-vs-Stage4
3.394800E-01
Stage1-vs-Stage2
8.516200E-01
Stage1-vs-Stage3
3.060200E-01
Stage1-vs-Stage4
5.826200E-01
Stage2-vs-Stage3
4.426200E-01
Stage2-vs-Stage4
4.360800E-01
Stage3-vs-Stage4
3.259800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.715900E-03
Normal-vs-AfricanAmerican
2.188200E-01
Normal-vs-Asian
4.969900E-02
Caucasian-vs-AfricanAmerican
7.286800E-01
Caucasian-vs-Asian
4.432000E-01
AfricanAmerican-vs-Asian
5.662400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.745920E-02
Normal-vs-Female
1.553970E-02
Male-vs-Female
4.960200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.034410E-01
Normal-vs-Age(41-60Yrs)
4.721700E-02
Normal-vs-Age(61-80Yrs)
1.153670E-02
Normal-vs-Age(81-100Yrs)
2.124000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.321200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.925800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.799000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.998210E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.704600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.156090E-02
Normal-vs-Daily Drinker
3.436500E-03
Normal-vs-Weekly Drinker
2.287900E-02
Normal-vs-Occasional Drinker
1.758110E-02
Normal-vs-Social Drinker
8.406400E-02
Non Drinker-vs-Daily Drinker
3.424600E-01
Non Drinker-vs-Weekly Drinker
8.844800E-01
Non Drinker-vs-Occasional Drinker
8.162200E-01
Non Drinker-vs-Social Drinker
1.934990E-01
Daily Drinker-vs-Weekly Drinker
5.177400E-01
Daily Drinker-vs-Occasional Drinker
2.696400E-01
Daily Drinker-vs-Social Drinker
4.071600E-02
Weekly Drinker-vs-Occasional Drinker
7.395600E-01
Weekly Drinker-vs-Social Drinker
2.248600E-01
Occasional Drinker-vs-Social Drinker
3.073000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.687810E-01
Normal-vs-Grade 2
1.068100E-02
Normal-vs-Grade 3
3.073800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.999800E-02
Grade 1-vs-Grade 3
1.003800E-01
Grade 1-vs-Grade 4
1.687810E-01
Grade 2-vs-Grade 3
9.232800E-01
Grade 2-vs-Grade 4
1.068100E-02
Grade 3-vs-Grade 4
3.073800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.395610E-02
Normal-vs-NonDiabetic
5.404500E-03
Diabetic-vs-NonDiabetic
8.619000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.111760E-02
Normal-vs-NoPancreatitis
8.360400E-03
Pancreatitis-vs-NoPancreatitis
4.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.474300E-02
Normal-vs-N1
1.509840E-02
N0-vs-N1
8.572800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.186200E-02
Normal-vs-TP53-NonMutant
4.698000E-02
TP53-Mutant-vs-TP53-NonMutant
9.701600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
